Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.5685
-0.0118 (-2.03%)
At close: Jul 31, 2026, 4:00 PM EDT
0.5500
-0.0185 (-3.25%)
After-hours: Jul 31, 2026, 7:47 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $19.98 million as of July 31, 2026. Its market cap has decreased by -82.15% in one year.
Market Cap
19.98M
Enterprise Value
3.18M
1-Year Change
-82.15%
Ranking
Category
Stock Price
$0.57
ChartMarket Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $19.98M, a decrease of -94.39%. That is a compound annual growth rate of -71.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 20.00M | -16.67% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 21.06M |
| Neuphoria Therapeutics | 20.97M |
| Cellectar Biosciences | 20.54M |
| CEL-SCI | 20.27M |
| Tvardi Therapeutics | 19.70M |
| GridAI Technologies | 19.29M |
| Allarity Therapeutics | 19.25M |
| Marker Therapeutics | 18.84M |